Results 231 to 240 of about 19,606,378 (347)

Therapeutic Monitoring of Patients With Hereditary Tyrosinemia Type 1-A Belgian Monocentric Experience. [PDF]

JIMD Rep
Adam AS, Marcélis L, Fage D, Mathieu E, Empain A, Dufour C, Cotton F, de Laet C.   +7 more
europepmc   +1 more source

Effects of Fluvastatin in Type 2 Diabetic Patients with Hyperlipidemia: Reduction in Cholesterol Oxidation Products and VCAM-1

, 2004
Jingzhi Guan, Hiroshi Murakami, Kazumi Yamato, Jutaro Tanabe, Jun Matsui, Naoki Tamasawa, Toshihiro Suda   +6 more
openalex   +2 more sources

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Divergent Enzymatic Synthesis of a Comprehensive Type‑1 Glycan Determinant Library. [PDF]

ACS Catal
Bai G, Shen T, Shabahang M, Bao S, Fan S, Lv H, Li L.   +6 more
europepmc   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Metachronous Pheochromocytoma and Cholangiocarcinoma in a patient with Neurofibromatosis type 1: a case report. [PDF]

Oxf Med Case Reports
Al Harrak Y, Lkhoyaali S, Lamsyah O, Boutayeb S, El Ghissassi I, M'rabti H, Errihani H.   +6 more
europepmc   +1 more source

Kidney injury molecules (KIM-1, MCP-1) and type IV collagen in the assessment of activity of antineutrophil cytoplasmic antibody-associated glomerulonephritis

, 2017
N. Bulanov, Anna Serova, E I Kuznetsova, Mayra Bulanova, Pavel Novikov, Lidia Kozlovskaya, Sergey Moiseev   +6 more
openalex   +1 more source

Urinary Alpha- and Pi-Glutathione S-Transferases in Adult Patients with Type 1 Diabetes [PDF]

, 2014
Bernt Johan von Scholten, Simone Theilade, Maria Lajer, Peter Rossing   +3 more
openalex   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes Prevention. [PDF]

Diabetes Care
You L, Parikh HM, Triolo TM, Ferrat LA, Templeman EL, Oram RA, Gottlieb PA, Rich SS, Onengut-Gumuscu S, Steck AK, Krischer J, Redondo MJ.   +11 more
europepmc   +1 more source